MEGAN ROBINSON: Open Payments
NPI 1730602426 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,637 in 90 payments from 19 companies in 2025. Trend: 2023 $2,034 · 2024 $1,875 · 2025 $1,637
Food & beverage: $1,560Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $319 |
| Novartis Pharmaceuticals Corporation | 9 | $208 |
| Janssen Biotech, Inc. | 8 | $180 |
| Lilly USA, LLC | 10 | $154 |
| Incyte Corporation | 5 | $104 |
| UCB, Inc. | 5 | $96 |
| LEO Pharma Inc. | 4 | $90 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $63 |
| PFIZER INC. | 3 | $55 |
| GENZYME CORPORATION | 2 | $54 |
Products named: TREMFYA, COSENTYX, SKYRIZI, RINVOQ, TALTZ, OPZELURA, Bimzelx, DUPIXENT.
Industry payments across MO — which companies pay providers there.
